Caspofungin combined with TMP/SMZ as a first‐line therapy for moderate‐to‐severe PCP in patients with human immunodeficiency virus infection
Sign Up to like & getrecommendations! Published in 2020 at "HIV Medicine"
DOI: 10.1111/hiv.13013
Abstract: The effectiveness of trimethoprim/sulfamethoxazole (TMP/SMZ) for pneumocystis pneumonia (PCP) is limited with adverse events. Caspofungin, by inhibiting the cyst form of Pneumocystis jirovecii, may be an alternative therapy for PCP. However, the availability of clinical… read more here.
Keywords: pcp; combined tmp; tmp smz; caspofungin combined ... See more keywords